# Hypertension Management Guidelines

## Definition and Classification

**Hypertension** is defined as persistently elevated blood pressure ≥140/90 mmHg.

### Blood Pressure Categories (AHA/ACC 2017)
- **Normal**: <120/80 mmHg
- **Elevated**: 120-129/<80 mmHg
- **Stage 1 Hypertension**: 130-139/80-89 mmHg
- **Stage 2 Hypertension**: ≥140/90 mmHg
- **Hypertensive Crisis**: >180/120 mmHg

## Risk Factors

### Non-Modifiable
- Age (men >55, women >65)
- Family history
- Race (higher prevalence in African Americans)

### Modifiable
- Obesity (BMI ≥30)
- Physical inactivity
- High sodium intake (>2.3g/day)
- Excessive alcohol consumption
- Smoking
- Chronic stress
- Sleep apnea

## Clinical Evaluation

### Initial Assessment
1. **History**: Family history, medications, lifestyle factors
2. **Physical Exam**: Multiple BP readings, cardiovascular examination
3. **Laboratory Tests**:
   - Complete metabolic panel
   - Lipid profile
   - Urinalysis
   - ECG
   - Echocardiogram (if indicated)

### Target Organ Damage
- **Cardiovascular**: Left ventricular hypertrophy, coronary artery disease
- **Cerebrovascular**: Stroke, transient ischemic attack
- **Renal**: Chronic kidney disease, proteinuria
- **Retinal**: Hypertensive retinopathy

## Treatment Approach

### Lifestyle Modifications (First-line for all patients)
1. **DASH Diet**: Fruits, vegetables, whole grains, lean proteins
2. **Sodium Restriction**: <2.3g/day (ideally <1.5g/day)
3. **Weight Management**: Target BMI 18.5-24.9
4. **Regular Exercise**: 150 min/week moderate aerobic activity
5. **Alcohol Limitation**: ≤2 drinks/day (men), ≤1 drink/day (women)
6. **Smoking Cessation**
7. **Stress Management**

### Pharmacological Treatment

#### First-Line Medications
1. **ACE Inhibitors** (lisinopril, enalapril)
   - Mechanism: Block angiotensin-converting enzyme
   - Side effects: Dry cough, hyperkalemia, angioedema

2. **ARBs** (losartan, valsartan)
   - Mechanism: Block angiotensin II receptors
   - Side effects: Hyperkalemia, less cough than ACE inhibitors

3. **Calcium Channel Blockers** (amlodipine, nifedipine)
   - Mechanism: Block calcium channels in vascular smooth muscle
   - Side effects: Peripheral edema, gingival hyperplasia

4. **Thiazide Diuretics** (hydrochlorothiazide, chlorthalidone)
   - Mechanism: Reduce sodium and water retention
   - Side effects: Hypokalemia, hyperuricemia, glucose intolerance

#### Combination Therapy
- Most patients require 2+ medications
- Fixed-dose combinations improve adherence
- Common combinations: ACE inhibitor + diuretic, ARB + CCB

## Blood Pressure Targets

### General Population
- **<65 years**: <130/80 mmHg
- **≥65 years**: <130/80 mmHg (if tolerated)

### Special Populations
- **Diabetes**: <130/80 mmHg
- **Chronic Kidney Disease**: <130/80 mmHg
- **Coronary Artery Disease**: <130/80 mmHg

## Monitoring and Follow-up

### Initial Management
- Recheck BP in 1-4 weeks after starting/changing medication
- Assess for side effects and adherence
- Monitor electrolytes and kidney function

### Stable Patients
- Office visits every 3-6 months
- Home BP monitoring encouraged
- Annual assessment of cardiovascular risk factors

## Hypertensive Emergency

### Definition
- BP >180/120 mmHg with acute end-organ damage
- Examples: Stroke, acute MI, acute heart failure, aortic dissection

### Management
- Immediate hospitalization
- IV antihypertensive agents
- Reduce BP by 10-20% in first hour
- Avoid rapid, excessive BP reduction

## Patient Education

### Key Points
1. Hypertension is often asymptomatic ("silent killer")
2. Importance of medication adherence
3. Lifestyle modifications are crucial
4. Regular monitoring and follow-up
5. Complications of untreated hypertension

### Self-Monitoring
- Proper BP measurement technique
- When to contact healthcare provider
- Medication timing and storage
- Recognition of side effects

Early detection, appropriate treatment, and good BP control significantly reduce cardiovascular morbidity and mortality.
